Search Within

Brian Carl Shaffer

  1. "2024"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
  3. Guidelines (1)
Groups
  1. Bone Marrow Transplant (12)
  2. Center for Hematologic Malignancies (12)
  3. Department of Medicine (12)
  4. Hematologic Malignancies, Division of (12)
  5. CTCR Scholars (4)
  6. Survivorship Research (4)

More Groups

People
  1. Esperanza Papadopoulos (4)
  2. Miguel-Angel Perales (4)
  3. Stephanie Chinapen (3)
  4. Andrew Lin (2)
  5. Boglarka Gyurkocza (2)
  6. Doris Ponce (2)

More People

Years
  1. 2024 (12)
Publications
  1. Bone Marrow Transplantation (4)
  2. Blood Advances (3)
  3. Journal of Clinical Oncology (2)
  4. Blood (1)
  5. European Heart Journal-Quality of Care and Clinical Outcomes (1)
  6. Transplantation and Cellular Therapy (1)
Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide
    Meeting Abstract

    Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Post-transplantation cyclophosphamide improves graft-versus-host disease-free, relapse-free survival in HLA-DPB1 mismatched unrelated donor allogeneic transplant
    Meeting Abstract

    McCurdy, S. R.; Solomon, S. R.; Shaffer, B. C.; He, M.; Bolon, Y. T.; Blouin, A. G.; Keyzner, A.; Socola, F. A.; Ibrahim, U.; Zou, J.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Young matched unrelated donors should be prioritized over older-aged matched sibling donors and young haploidentical donors in allogeneic transplantation with post-transplant cyclophosphamide in recipients ≥ 50-years
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Superior disease control with younger matched unrelated donor vs older-aged matched sibling donor in recipients ≥ 50-years with ALL, AML, or MDS using CNI-based GVHD prophylaxis
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in hospitalized patients with cancer and new versus preexistent atrial fibrillation
    Journal Article

    Kosmidou, I.; Durkin, M.; Vella, E.; Dejesus, N.; Romero, S.; Gamboa, R.; Jenkins, P.; Shaffer, B.; Steingart, R.; Liu, J.
    European Heart Journal-Quality of Care and Clinical Outcomes (2024)

    Fulltext@MSK | Save
  • ASTCT consensus recommendations on testing and treatment of patients with donor-specific anti-HLA antibodies
    Guidelines

    Kongtim, P.; Vittayawacharin, P.; Zou, J.; Srour, S.; Shaffer, B.; Shapiro, R. M.; Varma, A.; McGuirk, J.; Dholaria, B. R.; McCurdy, S. R.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors
    Journal Article

    Shaffer, B. C.; Gooptu, M.; DeFor, T. E.; Maiers, M.; Bolaños-Meade, J.; Abboud, R.; Briggs, A. D.; Khimani, F.; Modi, D.; Newcomb, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
    Journal Article

    Holtzman, N. G.; Curtis, L. M.; Salit, R. B.; Shaffer, B. C.; Pirsl, F.; Ostojic, A.; Steinberg, S. M.; Schulz, E.; Wilder, J. S.; Hughes, T. E.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save